Capital &
Talent Acquisition
Access to capital and the right people are two of the most critical determinants of success in cross-border biopharma. BioRich provides both — through one of the most extensive personal networks in the industry.
Capital Acquisition
For Chinese biotech companies seeking US-based investment, navigating the venture capital landscape is challenging without established relationships. BioRich provides warm, contextualized introductions to investors who are actively seeking exposure to Chinese biopharma innovation.
- Active relationships with 10+ US venture capital firms focused on biopharma
- Strategic investor introductions for Chinese biotechs seeking US-based funding
- Pre-meeting preparation: investor thesis alignment, pitch narrative, and Q&A readiness
- Follow-on fundraising support for portfolio companies
- Connections to family offices and crossover investors with biopharma mandates
Talent Acquisition
The right people — scientific leaders, business development executives, regulatory experts — are often the difference between a program that advances and one that stalls. BioRich's unrivaled network positions us to find and place the talent that cross-border programs require.
- Executive search for C-suite and VP-level scientific and commercial roles
- Network of 16,000+ LinkedIn connections and 30+ WeChat groups for candidate sourcing
- Cross-cultural placement expertise: US talent into China programs, Chinese scientists into US companies
- Business development, regulatory affairs, medical affairs, and commercial roles
- Board advisor introductions for governance and strategic positioning
Discuss Capital or Talent Needs
Tell us about your funding stage or recruitment challenge and we will identify the right connections.
Get in Touch